Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buhmann

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Brain : a Journal of Neurology|January 23, 2003
Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patientsC Buhmann, V Glauche, H J Stürenburg, et al.
European Journal of Neurology|April 21, 1999
Current status of multiple sclerosis therapy in Germany: a national surveyC Heesen, S Hauer, B Hadji-Abdolrahim, et al.
Neuro Endocrinology Letters|December 4, 2003
Plasma amino acids in ecstasy usersHans Joerg Stuerenburg, K Petersen, C Buhmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 18, 2016
The impact of Parkinson disease on patients' sexuality and relationshipC Buhmann, S Dogac, E Vettorazzi, et al.
Journal of Neurology|February 24, 2001
Workshop II: "neuroprotection"--the Lugano consensusP Riederer, T Brücke, C Buhmann, et al.
Fortschritte Der Neurologie-Psychiatrie|June 9, 2016
[Parkinson's Disease at the Border Between Inpatient and Outpatient Care]C Buhmann, H Bass, M Hahne, et al.
Journal of Neurology|May 12, 2011
Depression in Parkinson's diseaseJ Schwarz, P Odin, C Buhmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 13, 2023
Correction to: Role of dopamine agonists in Parkinson's disease therapyD Woitalla, C Buhmann, R Hilker-Roggendorf, et al.
Journal of Lipid Research|July 7, 2001
Characterization of four lipoprotein classes in human cerebrospinal fluidS Koch, N Donarski, K Goetze, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2023
Role of dopamine agonists in Parkinson's disease therapyD Woitalla, C Buhmann, R Hilker-Roggendorf, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Brain : a Journal of Neurology|January 23, 2003
Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patientsC Buhmann, V Glauche, H J Stürenburg, et al.
European Journal of Neurology|April 21, 1999
Current status of multiple sclerosis therapy in Germany: a national surveyC Heesen, S Hauer, B Hadji-Abdolrahim, et al.
Neuro Endocrinology Letters|December 4, 2003
Plasma amino acids in ecstasy usersHans Joerg Stuerenburg, K Petersen, C Buhmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 18, 2016
The impact of Parkinson disease on patients' sexuality and relationshipC Buhmann, S Dogac, E Vettorazzi, et al.
Journal of Neurology|February 24, 2001
Workshop II: "neuroprotection"--the Lugano consensusP Riederer, T Brücke, C Buhmann, et al.
Fortschritte Der Neurologie-Psychiatrie|June 9, 2016
[Parkinson's Disease at the Border Between Inpatient and Outpatient Care]C Buhmann, H Bass, M Hahne, et al.
Journal of Neurology|May 12, 2011
Depression in Parkinson's diseaseJ Schwarz, P Odin, C Buhmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 13, 2023
Correction to: Role of dopamine agonists in Parkinson's disease therapyD Woitalla, C Buhmann, R Hilker-Roggendorf, et al.
Journal of Lipid Research|July 7, 2001
Characterization of four lipoprotein classes in human cerebrospinal fluidS Koch, N Donarski, K Goetze, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 10, 2023
Role of dopamine agonists in Parkinson's disease therapyD Woitalla, C Buhmann, R Hilker-Roggendorf, et al.
Pageof 4